Inovio Pharmaceuticals Promising Results for INO-4800 for COVID-19
Inovio Pharmaceuticals (INO) announces promising results of a study focusing on the human immune responses induced by Inovio DNA vaccine candidate, INO-4800, against COVID-19, and variants of concern.
The results demonstrated that INO-4800 induced a robust T . . .
This content is for paid subscribers.
Today’s Highlights April 15, 2021